Your shopping cart is currently empty

KRAS G12D inhibitor 22 (compound 6) is a KRAS mutation inhibitor with high antitumor activity (IC50 < 100 nM), excellent selectivity, and low toxicity. It is applicable in breast cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | KRAS G12D inhibitor 22 (compound 6) is a KRAS mutation inhibitor with high antitumor activity (IC50 < 100 nM), excellent selectivity, and low toxicity. It is applicable in breast cancer research. |
| Targets&IC50 | KRas (G12D):<100 nM |
| In vitro | KRAS G12D inhibitor 22 effectively inhibits the growth of AGS cells (0.08-20 μM; 72 h) with an IC50 of less than 500 nM. It shows significant inhibitory activity against the KRAS G12D protein with an IC50 of less than 100 nM. Additionally, KRAS G12D inhibitor 22 demonstrates superior antiproliferative activity on ASPC-1 and AGS cells compared to MRTX1133, while offering better selectivity for other Kras G12C mutant cell lines. |
| In vivo | After a single administration of KRAS G12D inhibitor 22 (3, 5 mg/kg; i.v. and i.p.; 0-24 h), the compound reaches effective concentrations for inhibiting tumor cell growth and demonstrates favorable bioavailability in SD rats. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.